Biomarker analyses in CLEOPATRA: A phase Ill, placebo-controlled study of pertuzumab in HER2-positive, first -line metastatic breast cancer (MBC)

被引：30

作者：

Baselga, J.

Cortes, J.

Im, S-A

Clark, E.

Kiermaier, A.

Ross, G.

Swain, S. M.

机构：

[1] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA

[2] Harvard Univ, Sch Med, Boston, MA USA

[3] Vall dHebron Univ Hosp, Barcelona, Spain

[4] Seoul Natl Univ, Coll Med, Seoul, South Korea

[5] Roche Prod Ltd, Welwyn Garden City, Herts, England

[6] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland

[7] MedStar Washington Hosp Ctr, Washington, DC USA

来源：

关键词：

D O I：

10.1158/0008-5472.SABCS12-S5-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

S5-1

引用

页数：1